Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 4/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.75 |
| ▸ | ASAH2 | Q9NR71 | 2/20 | 0.71 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.70 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4133213 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL13863420 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973496 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL5527047 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22911186 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973426 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL24032894 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22973497 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22910831 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 | |
| SCHEMBL22910800 | 1.00 | CETP (1.00) | CETPTHRBMEN1KMT2AASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151073-A1 | COMPOSITION AND NANOPARTICLE SUITABLE FOR USE IN THE DELIVERY OF A THERAPEUTIC AGENT | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-07-17 | — | — | WO | claimed |
| EP-4584278-A1 | 2-AMINOPROPANE-1,3-DIOL-CAPPED CATIONIC PEPTOIDS FOR NUCLEIC ACID DELIVERY | Nutcracker Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2025137277-A1 | DEGRADABLE PEPTOIDS | NUTCRACKER THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20240307526-A1 | COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS | MEDICI THERAPEUTICS, INC. | 2024-09-19 | — | — | US | claimed |
| CN-118320191-A | Drug coated balloon catheter for non-vascular stenosis | 优敦力公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118236560-A | Drug coated balloon catheter for non-vascular stenosis | 优敦力公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4380949-A1 | COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS | Nutcracker Therapeutics, Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| WO-2024054617-A1 | 2-AMINOPROPANE-1,3-DIOL-CAPPED CATIONIC PEPTOIDS FOR NUCLEIC ACID DELIVERY | NUTCRACKER THERAPEUTICS, INC. (US) | 2024-03-14 | — | — | WO | claimed |
| EP-4228667-A1 | METHODS FOR REVERSING HEPATIC STEATOSIS | Brightseed, Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-20 | — | — | US | claimed |
| CN-108845051-B | Method for detecting sphingolipid in zebra fish brain tissue based on UHPLC-QTrap MS | 中国农业科学院农业质量标准与检测技术研究所 | 2021-07-06 | — | — | CN | claimed |
| CN-111281851-A | PH-targeted flexible nanoliposome with acne removing effect and preparation method thereof | 程定义 | 2020-06-16 | — | — | CN | claimed |
| EP-3562510-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | Genevant Sciences GmbH (CH) | 2019-11-06 | — | — | EP | claimed |
| WO-2018126084-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | PHASERX, INC. (US) | 2018-07-05 | — | — | WO | claimed |
| EP-1250119-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2007-10-03 | — | — | EP | claimed |
| EP-1250119-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2002-10-23 | — | — | EP | claimed |
| WO-2001054654-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2001-08-02 | — | — | WO | claimed |
| US-6235737-B1 | APPLYING COMPOUND TO ADJUST CERAMIDE CONCENTRATION | GILLETTE COMPANY, THE | 2001-05-22 | — | — | US | claimed |
| EP-0850056-A1 | TOPICAL ANTI-SKIN-CANCER PREPARATIONS | Beiersdorf Aktiengesellschaft (DE) | 1998-07-01 | — | — | EP | claimed |
| WO-1997009975-A1 | TOPICAL ANTI-SKIN-CANCER PREPARATIONS | BEIERSDORF AG (DE) | 1997-03-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | UGT1A10, AKR1B10, CCR10 | CETP 1182/4885THRB 3261/4885MEN1 1931/4885 |
| US-20240307526-A1 | COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS | TLR9, TLR3, MICA | CETP 121/4885THRB 4504/4885MEN1 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.